Review of the mechanisms of probiotic actions in the prevention of colorectal cancer

Nutrition Research

Volumn 37, Issue , 2017, Pages 1-19

  dos Reis, Sandra A ^a   da Conceição, Lisiane L ^a   Siqueira, Nathane P ^a   Rosa, Damiana D ^a   da Silva, Letícia L ^a   Peluzio, Maria do Carmo G ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Anticarcinogenic activity; Colorectal cancer; Health; Intestinal microbiota; Probiotics

Indexed keywords

BACTERIOCIN; IMMUNOGLOBULIN A; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; YOGHURT;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BACTERIAL STRAIN; BACTERIAL VIABILITY; BIFIDOBACTERIUM LONGUM; CANCER INCIDENCE; CANCER PREVENTION; CD4 CD8 RATIO; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMING UNIT; COLORECTAL CANCER; CYTOKINE RELEASE; DEGRADATION; DIET SUPPLEMENTATION; DIETARY INTAKE; FAECALIBACTERIUM PRAUSNITZII; GENE EXPRESSION REGULATION; GENOTOXICITY; HISTONE ACETYLATION; HUMAN; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOSTIMULATION; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SACCHAROMYCES BOULARDII; SYSTEMATIC REVIEW; COLORECTAL TUMOR; INTESTINE; METABOLISM; MICROBIOLOGY;

COLORECTAL NEOPLASMS; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINES; PROBIOTICS;

EID: 85007337541     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2016.11.009     Document Type: Review

References (95)

1. [1] World Health Organization, WHO global health observatory: cancer mortality and morbidity. [Internet]. Available from: http://www.who.int/gho/ncd/mortality_morbidity/cancer_text/en/, 2014.
2. [2] Haggar, F.A., Boushey, R.P., Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22 (2009), 191–197.
3. [3] Wu, N., Yang, X., Zhang, R., Li, J., Xiao, X., Hu, Y., et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol 66 (2013), 462–470.
4. [4] Serban, D.E., Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics. Cancer Lett 345 (2014), 258–270.
5. [5] Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., et al. Human gut microbiome and risk of colorectal cancer. J Natl Cancer Inst, 2013, 1–5.
6. [6] Chen, W., Liu, F., Ling, Z., Tong, X., Xiang, C., Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One 7 (2012), 1–9.
7. [7] FAO/WHO. Food and Agriculture Organization of the United Nations/World Health Organization, Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. 2001.
8. [8] Koboziev, I., Webb, C.R., Furr, K.L., Grisham, M.B., Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med 68 (2013), 122–133.
9. [9] Chang, J.H., Shim, Y.Y., Cha, S.K., Reaney, M.J.T., Chee, K.M., Effect of Lactobacillus acidophilus KFRI342 on the development of chemically induced precancerous growths in the rat colon. J Med Microbiol 61 (2012), 361–368.
10. [10] Zhu, J., Zhu, C., Ge, S., Zhang, M., Jiang, L., Cui, J., et al. Lactobacillus salivarius Ren prevent the early colorectal carcinogenesis in 1, 2-dimethylhydrazine-induced rat model. J Appl Microbiol 117 (2014), 208–216.
11. [11] Zhang, M., Fan, X., Fang, B., Zhu, C., Zhu, J., Ren, F., Effects of Lactobacillus salivarius Ren on cancer prevention and intestinal microbiota in 1, 2-dimethylhydrazine-induced rat model. J Microbiol 53 (2015), 398–405.
12. [12] Hatakka, K., Holma, R., El-Nezami, H., Suomalainen, T., Kuisma, M., Saxelin, M., et al. The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. Int J Food Microbiol 128 (2008), 406–410.
13. [13] Ohara, T., Yoshino, K., Kitajima, M., Possibility of preventing colorectal carcinogenesis with probiotics. Hepatogastroenterology 57 (2010), 1411–1415.
14. [14] Liu, Z., Qin, H., Yang, Z., Xia, Y., Liu, W., Yang, J., et al. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery: a double-blind study. Aliment Pharmacol Ther 33 (2011), 50–63.
15. [15] Zhu, Q., Gao, R., Wu, W., Qin, H., The role of gut microbiota in the pathogenesis of colorectal cancer. Tumor Biol 34 (2013), 1285–1300.
16. [16] Nowak, A., Slizewska, K., Blasiak, J., Libudzisz, Z., The influence of Lactobacillus casei DN 114 001 on the activity of faecal enzymes and genotoxicity of faecal water in the presence of heterocyclic aromatic amines. Anaerobe 30 (2014), 129–136.
17. [17] Mohania, D., Kansal, V.K., Sagwal, R., Shah, D., Anticarcinogenic effect of probiotic Dahi and piroxicam on DMH-induced colorectal carcinogenesis in Wistar rats. Am J Cancer Ther Pharmacol 1 (2013), 1–17.
18. [18] Verma, A., Shukla, G., Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH-induced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in Sprague Dawley rats. Nutr Cancer 65 (2013), 84–91.
19. [19] Tjalsma, H., Boleij, A., Marchesi, J.R., Dutilh, B.E., A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 10 (2012), 575–582.
20. [20] Bolognani, F., Rumney, C.J., Rowland, I.R., Influence of carcinogen binding by lactic acid-producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens. Food Chem Toxicol 35 (1997), 535–545.
21. [21] Burns, A.J., Rowland, I.R., Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutat Res 551 (2004), 233–243.
22. [22] Vipperla, K., O'Keefe, S.J., The microbiota and its metabolites in colonic mucosal health and cancer risk. Nutr Clin Pract 27 (2012), 624–635.
23. [23] Weir, T.L., Manter, D.K., Sheflin, A.M., Barnett, B.A., Heuberger, A.L., Ryan, E.P., Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 8 (2013), 1–10.
24. [24] Chen, H.-M., Yu, Y.-N., Wang, J.-L., Lin, Y.-W., Kong, X., Yang, C.-Q., et al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr 97 (2013), 1044–1052.
25. [25] Kumar, M., Nagpal, R., Verma, V., Kumar, A., Kaur, N., Hemalatha, R., et al. Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr Rev 71 (2012), 23–34.
26. [26] Irrazábal, T., Belcheva, A., Girardin, S.E., Martin, A., Philpott, D.J., The multifaceted role of the intestinal microbiota in colon cancer. Mol Cell 54 (2014), 309–320.
27. [27] Femia, A.P., Luceri, C., Dolara, P., Giannini, A., Biggeri, A., Salvadori, M., et al. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23 (2002), 1953–1960.
28. [28] Worthley, D.L., Leu, R.K.L., Whitehall, V.L., Conlon, M., Christophersen, C., Belobrajdic, D., et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr 90 (2009), 578–586.
29. [29] Tedelind, S., Westberg, F., Kjerrulf, M., Vidal, A., Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 13 (2007), 2826–2832.
30. [30] Hosseini, E., Grootaert, C., Verstraete, W., de Wiele, T.V., Propionate as a health-promoting microbial metabolite in the human gut. Nutr Rev 69 (2011), 245–258.
31. [31] Ewaschuk, J.B., Walker, J.W., Diaz, H., Madsen, K.L., Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J Nutr 136 (2006), 1483–1487.
32. [32] Bassaganya-Riera, J., Viladomiu, M., Pedragosa, M., Simone, C., Hontecillas, R., Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS One 7 (2012), 1–8.
33. [33] Arthur, J.C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T.J., et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338 (2012), 120–123.
34. [34] Corthésy, B., Gaskins, H.R., Mercenier, A., Cross-talk between probiotic bacteria and the host immune system. J Nutr 137 (2007), 781–790.
35. [35] Delcenserie, V., Martel, D., Lamoureux, M., Amiot, J., Boutin, Y., Roy, D., Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol 10 (2008), 37–54.
36. [36] Urbanska, A.M., Paul, A., Bhahena, J., Prakash, S., Suppression of tumorigenesis: modulation of inflammatory cytokines by oral administration of microencapsulated probiotic yogurt formulation. Int J Inflamm 2010 (2010), 1–10.
37. [37] Isolauri, E., Sütas, Y., Kankaanpää, P., Arvilommi, H., Salminen, S., Probiotics: effects on immunity. Am J Clin Nutr 73 (2001), 444–450.
38. [38] Vinderola, G., Perdigón, G., Duarte, J., Farnworth, E., Matar, C., Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity. Cytokine 36 (2006), 254–260.
39. [39] Galdeano, C.M., Perdigón, G., The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol 13 (2007), 219–226.
40. [40] Foo, N.-P., Yang, H.O., Chiu, H.-H., Chan, H.-Y., Liao, C.-C., Yu, C.-K., et al. Probiotics prevent the development of 1,2-dimethylhydrazine (DMH)–induced colonic tumorigenesis through suppressed colonic mucosa cellular prolife ration and increased stimulation of macrophages. J Agric Food Chem 59 (2011), 13337–13345.
41. [41] Lee, H.A., Kim, H., Lee, K.-W., Park, K.-Y., Dead nano-sized Lactobacillus plantarum inhibits azoxymethane/dextran sulfate sodium–induced colon cancer in Balb/c mice. J Med Food 18 (2015), 1400–1405.
42. [42] Vinderola, G., Perdigon, G., Duarte, J., Thangavel, D., Farnworth, E., Matar, C., Effects of kefir fractions on innate immunity. Immunobiology 211 (2006), 149–156.
43. [43] Galdeano, C.M., LeBlanc, A.M., Vinderola, G., Bonet, M.E.B., Perdigón, G., Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine Immunol 14 (2007), 485–492.
44. [44] Schwabe, R.F., Jobin, C., The microbiome and cancer. Nature 13 (2013), 800–812.
45. [45] Madsen, K.L., Enhancement of epithelial barrier function by probiotics. J Epithel Biol Pharmacol 5 (2012), 55–59.
46. [46] Ohigashi, S., Sudo, K., Kobayashi, D., Takahashi, O., Takahashi, T., Asahara, T., et al. Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig Dis Sci 58 (2013), 1717–1726.
47. [47] Liu, J.R., Wang, S.Y., Chen, M.J., Yueh, P.Y., Lin, C.W., The anti-allergenic properties of milk kefir and soymilk kefir and their beneficial effects on the intestinal microflora. J Sci Food Agric 86 (2006), 2527–2533.
48. [48] Boleij, A., Tjalsma, H., Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol Rev 87 (2012), 701–730.
49. [49] Ohland, C.L., MacNaughton, W.K., Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 298 (2010), 807–819.
50. [50] Karczewski, J., Troost, F.J., Konings, I., Dekker, J., Kleerebezem, M., Brummer, R.J.M., et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 289 (2010), 851–859.
51. [51] Carasi, P., Racedo, M., Jacquot, C., Romanin, D.E., Serradell, M.A., Urdaci, M.C., Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota. J Immunol Res, 2014, 1–12.
52. [52] Caballero-Franco, C., Keller, K., De Simone, C., Chadee, K., The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292 (2007), 315–322.
53. [53] Gaudier, E., Michel, C., Segain, J.-P., Cherbut, C., Hoebler, C., The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate–induced colitis or reinforce the mucus barrier in mice. J Nutr 135 (2005), 2753–2761.
54. [54] Kumar, R.S., Kanmani, P., Yuvaraj, N., Paari, K.A., Pattukumar, V., Thirunavukkarasu, C., et al. Lactobacillus plantarum AS1 isolated from South Indian fermented food Kallappam suppress 1,2-dimethylhydrazine (DMH)-induced colorectal cancer in male Wistar rats. Appl Biochem Biotechnol 166 (2012), 620–631.
55. [55] Pool-Zobel, B., Veeriah, S., Bohmer, F.D., Modulation of xenobiotic metabolising enzymes by anticarcinogens—focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res 591 (2005), 74–92.
56. [56] Milovic, V., Turchanowa, L., Polyamines and colon cancer. Biochem Soc Trans 31 (2003), 381–383.
57. [57] Singh, J., Rivenson, A., Tomita, M., Shimamura, S., Ishibashi, N., Reddy, B.S., Bifidobacterium longum, a lactic acid–producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18 (1997), 833–841.
58. [58] Fearon, E.R., Molecular genetics of colorectal cancer. Annu Rev Pathol Mech 6 (2011), 479–507.
59. [59] Thirabunyanon, M., Boonprasom, P., Niamsup, P., Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on antiproliferation of colon cancer cells. Biotechnol Lett 31 (2009), 571–576.
60. [60] Sadeghi-Aliabadi, H., Mohammadi, F., Fazeli, H., Mirlohi, M., Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain. Iran J Basic Med Sci 17 (2014), 815–819.
61. [61] LeBlanc, A.M., Perdigón, G., Yogurt feeding inhibits promotion and progression of experimental colorectal cancer. Med Sci Monit 10 (2004), 96–104.
62. [62] Wan, Y., Xin, Y., Zhang, C., Wu, D., Ding, D., Tang, L., et al. Fermentation supernatants of Lactobacillus delbrueckii inhibit growth of human colon cancer cells and induce apoptosis through a caspase 3–dependent pathway. Oncol Lett 7 (2014), 1738–1742.
63. [63] Sears, C.L., Pardoll, D.M., Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J Infect Dis 203 (2011), 306–311.
64. [64] Castellarin, M., Warren, R.L., Freeman, D.J., Dreolini, L., Krzywinski, M., Strauss, J., et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22 (2012), 299–306.
65. [65] Marchesi, J.R., Dutilh, B.E., Hall, N., Peters, W.H.M., Roelofs, R., Boleij, A., et al. Towards the human colorectal cancer microbiome. PLoS One, 6, 2011.
66. [66] McCoy, A.N., Araújo-Pérez, F., Azcárate-Peril, A., Yeh, J.J., Sandler, R.S., Keku, T.O., Fusobacterium is associated with colorectal adenomas. PLoS One 8 (2013), 1–8.
67. [67] Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J.P., Letulle, S., Langella, P., et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 6 (2011), 1–7.
68. [68] Maldonado-Gómez, M.X., Martínez, I., Bottacini, F., O'callaghan, A., Ventura, M., Van Sinderen, D., et al. Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. Cell Host Microbe 20 (2016), 1–12.
69. [69] Lee, N.-K., Park, J.-S., Park, E., Paik, H.-D., Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine. Lett Appl Microbiol 44 (2007), 274–278.
70. [70] Kim, Y., Lee, D., Kim, D., Cho, J., Yang, J., Chung, M., et al. Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Arch Pharm Res 31 (2008), 468–473.
71. [71] Koller, V.J., Marian, B., Stidl, R., Nersesyan, A., Winter, H., Simic, T., et al. Impact of lactic acid bacteria on oxidative DNA damage in human derived colon cells. Food Chem Toxicol 46 (2008), 1221–1229.
72. [72] Altonsy, M.O., Andrews, S.C., Tuohy, K.M., Differential induction of apoptosis in human colonic carcinoma cells (Caco-2) by Atopobium, and commensal, probiotic and enteropathogenic bacteria: mediation by the mitochondrial pathway. Int J Food Microbiol 137 (2010), 190–203.
73. min mice. Gastroenterology 137 (2009), 914–992.
74. [74] Ma, E.L., Choi, Y.J., Choi, J., Pothoulakis, C., Rhee, S.H., Im, E., The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediate d through ErbB 2 and ErbB 3 inhibition. Int J Cancer 127 (2010), 780–790.
75. [75] Grishina, A., Kulikova, I., Alieva, L., Dodson, A., Rowland, I., Jin, J., Antigenotoxic effect of kefir and ayran supernatants on fecal water-induced DNA damage in human colon cells. Nutr Cancer 63 (2011), 73–79.
76. [76] Orlando, A., Refolo, M.G., Messa, C., Amati, L., Lavermicocca, P., Guerra, V., et al. Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines. Nutr Cancer 64 (2012), 1103–1111.
77. [77] Thirabunyanon, M., Hongwittayakorn, P., Potential probiotic lactic acid bacteria of human origin induce antiproliferation of colon cancer cells via synergic actions in adhesion to cancer cells and short-chain fatty acid bioproduction. Appl Biochem Biotechnol 169 (2013), 511–525.
78. [78] Shyu, P.T., Oyong, G.G., Cabrera, E.C., Cytotoxicity of probiotics from Philippine commercial dairy products on cancer cells and the effect on expression of cfos and cjun early apoptotic-promoting genes and interleukin-1beta and tumor tecrosis factor–alfa proinflammatory cytokine genes. Biomed Res Int, 2014, 1–9.
79. [79] Chen, Z.-F., Ai, L.-Y., Wang, J.-L., Ren, L.-L., Yu, Y.-N., Xu, J., et al. Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis. Future Microbiol 10 (2015), 1433–1445.
80. [80] Dallal, M.M.S., Mojarrad, M., Baghbani, F., Raoofian, R., Mardaneh, J., Salehipour, Z., Effects of probiotic Lactobacillus acidophilus and Lactobacillus casei on colorectal tumor cells activity (CaCo-2). Arch Iran Med 18 (2015), 167–172.
81. [81] Nouri, Z., Karami, F., Neyazi, N., Modarressi, M.H., Karimi, R., Khorramizadeh, M.R., et al. Dual anti-metastatic and anti-proliferative activity assessment of two probiotics on HeLa and HT-29 cell lines. Cell 18 (2016), 127–134.
82. [82] Park, E., Jeon, G.-I., Park, J.-S., Paik, H.-D., A probiotic strain of Bacillus polyfermenticus reduces DMH induced precancerous lesions in F344 male rat. Biol Pharm Bull 30 (2007), 569–574.
83. [83] Sivieri, K., Spinardi-Barbisan, A.L.T., Barbisan, L.F., Bedani, R., Pauly, N.D., Carlos, I.Z., et al. Probiotic Enterococcus faecium CRL 183 inhibit chemically induced colon cancer in male wistar rats. Eur Food Res Technol 228 (2008), 231–237.
84. [84] Purohit, D.H., Hassan, A.N., Bhatia, E., Zhang, X., Dwivedi, C., Rheological, sensorial, and chemopreventive properties of milk fermented with exopolysaccharide-producing lactic cultures. Am Dairy Sci Assoc 92 (2009), 847–856.
85. [85] Kim, S.W., Kim, H.M., Yang, K.M., Kim, S.-A., Kim, S.-K., An, M.J., et al. Bifidobacterium lactis inhibits NF-kB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice. Inflamm Bowel Dis 16 (2010), 1514–1525.
86. [86] Kumar, A., Singh, N.K., Sinha, P.R., Inhibition of 1,2-dimethylhydrazine induced colon genotoxicity in rats by the administration of probiotic curd. Mol Biol Rep 37 (2010), 1373–1376.
87. [87] Leu, R.K.L., Hu, Y., Brown, I.L., Woodman, R.J., Young, G.P., Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 31 (2010), 246–251.
88. [88] Narushima, S., Sakata, T., Hioki, K., Itoh, T., Nomura, T., Itoh, K., Inhibitory effect of yogurt on aberrant crypt foci formation in the rat colon and colorectal tumorigenesis in RasH2 mice. Exp Anim 59 (2010), 487–494.
89. [89] Appleyard, C.B., Cruz, M.L., Isidro, A.A., Arthur, J.C., Jobin, C., De Simone, C., Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. Am J Physiol Gastrointest Liver Physiol 301 (2011), 1004–1013.
90. [90] Chen, C.-C., Lin, W.-C., Kong, M.-S., Shi, H.N., Walker, W.A., Lin, C.-Y., et al. Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue. Br J Nutr 107 (2012), 1623–1634.
91. [91] Urbanska, A.M., Bhathena, J., Cherif, S., Prakash, S., Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis. Artif Cells Nanomed Biotechnol, 1-11, 2012.
92. [92] Liboredo, J.C., Anastácio, L.R., Pelúzio, M.C.G., Valente, F.X., Penido, L.C.P., Nicoli, J.R., et al. Effect of probiotics on the development of dimethylhydrazine-induced preneoplastic lesions in the mice colon. Acta Cir Bras 28 (2013), 367–372.
93. [93] Verma, A., Shukla, G., Synbiotic (Lactobacillus rhamnosus + Lactobacillus acidophilus + inulin) attenuates oxidative stress and colonic damage in 1,2 dimethylhydrazine dihydrochloride–induced colon carcinogenesis in Sprague–Dawley rats: a long-term study. Eur J Cancer Prev 23 (2014), 550–559.
94. [94] Walia, S., Kamal, R., Kanwar, S.S., Dhawan, D.K., Cyclooxygenase as a target in chemoprevention by probiotics during 1,2-dimethylhydrazine induced colon carcinogenesis in rats. Nutr Cancer, 2015, 1–9 [0].
95. [95] Pala, V., Sieri, S., Berrino, F., Vineis, P., Sacerdote, C., Palli, D., et al. Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort. Int J Cancer 129 (2011), 2712–2719.